- Home
- AQMS vs CNSP Comparison
AQMS vs CNSP Comparison
Compare AQMS & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AQMS | CNSP |
|---|---|---|
| Founded | 2014 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3M | 7.5M |
| IPO Year | 2015 | 2019 |
Fundamental Metrics
Financial Performance| Metric | AQMS | CNSP |
|---|---|---|
| Price | $2.69 | $5.40 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $12.00 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 27.2K | 5.7K |
| Earning Date | 05-05-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 8.03 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,100,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $600.00 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.46 | $1.90 |
| 52 Week High | $39.37 | $10.59 |
Technical Indicators
Market Signals| Indicator | AQMS | CNSP |
|---|---|---|
| Relative Strength Index (RSI) | 48.62 | 54.59 |
| Support Level | $2.49 | $4.58 |
| Resistance Level | $2.98 | $5.72 |
| Average True Range (ATR) | 0.19 | 0.32 |
| MACD | 0.04 | -0.01 |
| Stochastic Oscillator | 63.45 | 72.27 |
Price Performance
Historical ComparisonAbout AQMS Aqua Metals Inc.
Aqua Metals Inc is developing and seeking to commercialize proprietary recycling and refining technologies for the recovery of critical minerals and metals. Its patented and patent-pending AquaRefining process is an electro-hydrometallurgical method designed to recover high-purity materials from battery and other metal-bearing feedstocks using a closed-loop system powered by electricity. Its idea is to reduce CAPEX and OPEX costs, reduce emissions, hazardous waste, and reliance on conventional smelting and chemical-intensive refining processes. It has one operating segment: sustainable metals recycling. It focused on the development and commercialization of AquaRefining technology for the clean and efficient recovery of valuable metals from lead-acid and lithium-ion batteries.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.